by jtcir-auto | Nov 4, 2021 | Press Releases
– Company continues to build strong developmental pipeline – Supported by solid cash position TORONTO, ONTARIO, Nov. 04, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a...
by jtcir-auto | Nov 4, 2021 | Press Releases
– Company continues to build strong developmental pipeline – Supported by solid cash position TORONTO, ONTARIO, Nov. 04, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a...
by jtcir-auto | Sep 8, 2021 | Press Releases
CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic...
by jtcir-auto | Sep 8, 2021 | Press Releases
CHARLESTON, S.C., Sept. 08, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic...
by jtcir-auto | Aug 4, 2021 | Press Releases
– Company continues to advance clinical and preclinical programswith its diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need- Strong balance sheet withcurrent cash of approximately $70 million...